Galanin/alpha2-receptor interactions in central cardiovascular control

Neuropharmacology. 2000 Jun 8;39(8):1377-85. doi: 10.1016/s0028-3908(99)00225-7.

Abstract

The modulation of the central cardiovascular effects of alpha(2)-adrenoceptor activation by galanin and its N-terminal fragment galanin-(1-15) has been evaluated by quantitative receptor autoradiography and cardiovascular analysis. Intracisternal coinjections of threshold doses of galanin and the selective and hypotensive alpha(2)-receptor agonist clonidine induced rapid and maintained vasopressor and tachycardic responses (p<0.001) instead of a hypotensive response, whereas the coinjections of threshold doses of the N-terminal galanin fragment (1-15) and clonidine did not elicit significant cardiovascular changes. Receptor autoradiographical experiments showed that galanin (1 nM) significantly increased the K(d) (p<0.01) and B(max) values (p<0.01) of [(3)H]p-Aminoclonidine binding sites in the nucleus tractus solitarii (NTS) compatible with a possible antagonistic interaction with the alpha(2)-adrenoceptors, and this effect was blocked by the presence of the specific galanin receptor antagonist M35. In addition, clonidine (30 nM) induced a 50% increase in the B(0) values of galanin based on competition experiments with [(125)I]-galanin binding in the NTS. These findings suggest the existence of an antagonistic effect of galanin, but not of galanin fragment (1-15), on the cardiovascular responses mediated by alpha(2)-receptors as well as a reciprocal facilitatory effect of alpha(2)-receptors on galanin binding. These mechanisms could be mediated by a reciprocal galanin-alpha(2) receptor interaction within the NTS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Agonists / pharmacology
  • Animals
  • Autoradiography
  • Binding, Competitive / drug effects
  • Blood Pressure / drug effects
  • Bradykinin / analogs & derivatives
  • Bradykinin / pharmacology
  • Cardiovascular Physiological Phenomena / drug effects*
  • Clonidine / analogs & derivatives
  • Clonidine / metabolism
  • Clonidine / pharmacology
  • Dose-Response Relationship, Drug
  • Galanin / metabolism
  • Galanin / pharmacology*
  • Kinetics
  • Male
  • Peptide Fragments / pharmacology
  • Protein Binding
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Adrenergic, alpha-2 / metabolism*
  • Receptors, Galanin
  • Receptors, Neuropeptide / antagonists & inhibitors
  • Solitary Nucleus / drug effects
  • Solitary Nucleus / metabolism
  • Specific Pathogen-Free Organisms
  • Tritium

Substances

  • Adrenergic alpha-Agonists
  • Peptide Fragments
  • Receptors, Adrenergic, alpha-2
  • Receptors, Galanin
  • Receptors, Neuropeptide
  • Tritium
  • galanin-(1-13)-bradykinin-(2-9)-amide
  • apraclonidine
  • Galanin
  • Clonidine
  • Bradykinin